NCT02545738View on ClinicalTrials.gov

Antiproteinuric Effects of Liraglutide Treatment

PHASE4CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Diabetic Kidney Disease

Interventions

DRUG

Liraglutide

active treatment

DRUG

placebo

placebo

Trial Locations (1)

2820

Peter Rossing, Gentofte Municipality

Sponsors

Collaborators (1)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Novo Nordisk A/S

INDUSTRY

lead

Steno Diabetes Center Copenhagen

OTHER